Skip to main content

Advertisement

Table 1 Baseline characteristics of the patients (per protocol population)

From: Gaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial

  Gaviscon® N = 120 Omeprazole N = 121
Age, years: mean (SD) 46.3 (10.7) 44.5 (12.2)
Women: N (%) 73 (60.8) 65 (53.7)
Weight, kg: mean (SD) 73.3 (14.8) 74.5 (16.1)
BMI, kg/m2: mean (SD) 26.0 (5.2) 26.2 (4.7)
BMI ≥ 30 kg/m2: N (%) 19 (15.8) 23 (19.0)
GERD, time to diagnosis, years: mean (SD) 4.7 (6.3) 5.3 (7.3)
History of upper endoscopy: N (%) 34 (28.3) 44 (36.4)
Number of days with heartburn per week
- 2: N (%) 9 (7.5) 6 (5.0)
- 3: N (%) 29 (24.2) 24 (19.8)
- 4: N (%) 35 (29.2) 27 (22.3)
- 5: N (%) 17 (14.2) 28 (23.1)
- 6: N (%) 30 (25.0) 36 (29.8)
- Mean: N (SD) 4.3 (1.3) 4.5 (1.2)
Heartburn
- Mild: N (%) 10 (8.3) 15 (12.4)
- Moderate: N (%) 83 (69.2) 73 (60.3)
- Severe: N (%) 27 (22.5) 33 (27.3)
Heartburn-related pain (VAS), mm: mean (SD) 52 (22) 53 (22)
Systolic BP, mmHg: mean (SD) 124.8 (10.8) 125.4 (11.0)
Diastolic BP, mmHg: mean (SD) 74.4 (8.5) 74.2 (8.2)
Heart rate, beat/min: mean (SD) 72.6 (7.5) 72.1 (9.0)
Smoking, Yes: N (%) 26 (21.7) 27 (22.3)
Alcohol consumption, Yes: N (%) 29 (24.2) 37 (30.6)
Living alone: N (%) 25 (20.8) 37 (30.6)
In couple: N (%) 95 (79.2) 84 (69.4)
Place of residence
- Rural 37 (30.8) 37 (30.6)
- Suburban 35 (29.2) 34 (28.1)
- Town 33 (27.5) 25 (20.7)
- City 15 (12.5) 25 (20.7)
Occupationally active 91 (75.8) 80 (66.1)